Navigation Links
OrthoAccel Technologies, Inc. Names U.S. National Sales Director
Date:5/30/2012

HOUSTON, May 30, 2012 /PRNewswire/ -- OrthoAccel Technologies, Inc., makers of AcceleDent™, a new device to accelerate orthodontic treatment, welcomes Christopher J. Bodish to the newly created position of United States National Sales Director. Mr. Bodish will oversee direct field sales in all United States market territories.

Taking this position is a natural career progression for him. Until recently, Mr. Bodish worked with OrthoAccel as a consultant. He brings to the position vast experience and a remarkably successful track record in sales and sales management. During his thirty years in the orthodontic industry he's made countless contributions to the field, including a long and distinguished career with perennial market leader DENTSPLY GAC International.

Mr. Bodish will report to Dwight Schnaitter, Vice President of Sales, who comments, "The most exciting attribute Chris brings to OrthoAccel is his leadership. He carries forward proven success in managing many of the areas that will require our focus. These include territory growth, talent recruitment and training, opinion leader management, and commitment to an educational and partnership-based selling approach."

In related news, OrthoAccel was pleased to introduce AcceleDent at the 112th Annual Session of the American Association of Orthodontists, held May 4–8 in Honolulu. OrthoAccel's exhibit included an international kiosk, complemented by a theatre setting for presenting a series of educational "microlectures" on a number of subjects, including the scientific and clinical evidence supporting AcceleDent.

In order to accommodate growth, the Houston-based company recently finalized plans to move to a larger facility.

About OrthoAccel® Technologies, Inc.

OrthoAccel's AcceleDent™ product provides faster tooth movement through its FDA approved solution, available now in over fifteen countries around the world.  AcceleDent™ works with all existing orthodontic solutions, including standard brackets and aligners, requiring only twenty minutes per day of regular usage.  OrthoAccel was founded in 2007 to commercialize research conducted by Dr. Jeremy Mao, DDS, PhD and Professor, Columbia University College of Dental Medicine.


'/>"/>
SOURCE OrthoAccel Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. OrthoAccel® Technologies, Inc. Announces Definitive Distribution Agreement in Italy
2. OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase
3. Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on May 14, 2012
4. Palatin Technologies, Inc. To Report Fiscal Year 2012 Third Quarter Results; Teleconference and Webcast to be held on May 14, 2012
5. AquaLiv Technologies, Inc. and Its Subsidiary, AquaLiv, Inc., Release Funding Updates
6. Palatin Technologies, Inc. to Present at the 24th Annual ROTH OC Growth Stock Conference
7. Cell Therapy - Technologies, Markets and Companies
8. Cytogenetics - Technologies, Markets and Companies
9. Senesco Technologies, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
10. Biomarkers - Technologies, Markets and Companies
11. Gene Therapy - Technologies, Markets and Companies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 2017  BioPharmX Corporation (NYSE MKT: BPMX), a ... market, today reported financial results for the quarter ... provide an update on the company,s clinical development ... "We are pleased to report that last year ... President Anja Krammer. "We achieved key clinical milestones ...
(Date:3/23/2017)... 2017 According to a report by Transparency ... fragmented due to the presence of a large pool of participants; ... Fisher , and Sigma-Aldrich, compete with each other in this market. ... more than 76% of this market in 2016.  ... As of now, a large number ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. ... Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate ... U.K. Biobank resource. The initiative will enable researchers to gain ... medicines for a wide range of serious and life threatening ... ...
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017 ... announced that it has eclipsed the 130 million covered ... Cross Blue Shield of Texas . ... stages, the Company continues to enjoy strong payor acceptance ... of its clinical programs and genetic counseling, its industry-leading ...
Breaking Biology Technology:
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics ... ...
(Date:3/9/2017)... FRANCISCO and MOUNTAIN VIEW, Calif. ... , "Eating Well Made Simple," and 23andMe , ... help guide better food choices.  Zipongo can now provide ... their food preferences, health goals and biometrics, but also ... certain food choices. Zipongo,s personalized food decision ...
(Date:3/2/2017)... , March 2, 2017 Summary ... better understand Merck KGaA and its partnering interests and ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
Breaking Biology News(10 mins):